Heidi Fischer
Overview
Explore the profile of Heidi Fischer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1672
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benz L, Mukherjee R, Wang R, Arterburn D, Fischer H, Lee C, et al.
Am J Epidemiol
. 2025 Jan;
PMID: 39745797
Target trial emulation (TTE) is a popular framework for observational studies based on electronic health records (EHR). A key component of this framework is determining the patient population eligible for...
2.
Levis A, Mukherjee R, Wang R, Fischer H, Haneuse S
Stat Med
. 2024 Dec;
43(30):6086-6098.
PMID: 39638313
Missing data arise in most applied settings and are ubiquitous in electronic health records (EHR). When data are missing not at random (MNAR) with respect to measured covariates, sensitivity analyses...
3.
Xia M, An J, Fischer H, Allen N, Xanthakis V, Zhang Y
Am J Hypertens
. 2024 Sep;
38(1):38-45.
PMID: 39325713
Background: Studying the association between blood pressure (BP) trajectories during young adulthood and subsequent cardiovascular disease (CVD) risk can provide insights into how long-term BP patterns in early-life influence the...
4.
An J, Fischer H, Ni L, Xia M, Choi S, Morrissette K, et al.
J Am Heart Assoc
. 2024 Apr;
13(8):e033053.
PMID: 38563367
Background: Blood pressure (BP) trajectories from young adulthood through middle age are associated with cardiovascular risk. We examined the associations of hypertension risk factors with BP trajectories among a large...
5.
Ku J, Fischer H, Qian L, Li K, Skarbinski J, Shaw S, et al.
Clin Infect Dis
. 2024 Jan;
78(5):1304-1312.
PMID: 38207124
Background: Tuberculosis (TB) is a public health threat, with >80% of active TB in the United States occurring due to reactivation of latent TB infection (LTBI). We may be underscreening...
6.
Lonky N, Chiu V, Portugal C, Estrada E, Chang J, Fischer H, et al.
PLoS One
. 2023 Dec;
18(12):e0294925.
PMID: 38079406
Background: Uterine leiomyomas and adenomyosis are both common and often associated with abnormal uterine bleeding (AUB), including the symptom of heavy menstrual bleeding (HMB). Understanding the prevalence of adenomyosis in...
7.
Fischer H, Qian L, Li Z, Garba S, Bruxvoort K, Skarbinski J, et al.
Open Forum Infect Dis
. 2023 Nov;
10(11):ofad545.
PMID: 38023560
Background: California has the largest number of tuberculosis (TB) disease cases in the United States. This study in a large California health system assessed missed opportunities for latent tuberculosis (LTBI)...
8.
Winckler K, Uggen Rasmussen M, Laugenborg J, Bukkehave K, Fischer H, Heitmann B, et al.
Acta Odontol Scand
. 2023 Nov;
83:30-37.
PMID: 37982800
Objectives: Periodontitis in pregnancy represents a significant, but often overlooked challenge due to its association to adverse pregnancy (preeclampsia and gestational diabetes) and birth related outcomes (preterm birth and low...
9.
Bruxvoort K, Fischer H, Lewnard J, Hong V, Pomichowski M, Grant L, et al.
Pneumonia (Nathan)
. 2023 Oct;
15(1):15.
PMID: 37794443
Background: Respiratory pathogens, including SARS-CoV-2, can cause pulmonary structural damage and physiologic impairment, which may increase the risk of subsequent lower respiratory tract infections (LRTI). Prior hospitalization for any reason...
10.
Skarbinski J, Fischer H, Hong V, Liu L, Yau V, Incerti D, et al.
Clin Pharmacol Ther
. 2023 Aug;
114(5):1073-1081.
PMID: 37571812
Randomized controlled trials (RCTs) remain the gold standard for evaluating treatment efficacy, but real-world evidence can supplement RCT results. Tocilizumab was not found to reduce 28-day mortality in a phase...